Trancura Biosciences
About:
Trancura Biosciences is a biotechnology company that uses targeted genomic approaches for the de nov design of monoclonal antibodies.
Description:
Trancura Biosciences is a biotechnology company that uses targeted genomic approaches for the de nov design of monoclonal antibodies. The company develops efficient screenings based on molecular immune profiling to accelerate the discovery of new monoclonal antibodies for biomedical relevant molecular targets. The company is headquartered in Emeryville, California.
Total Funding Amount:
$972000
Headquarters Location:
Emeryville, California, United States
Founded Date:
2019-01-01
Founders:
Number of Employees:
Last Funding Date:
2022-01-07
IPO Status:
Private
Industries:
© 2025 bioDAO.ai